Micropulse laser for managing DME
Despite the evidence demonstrating its efficacy and safety, subthreshold micropulse laser has faced several obstacles to adoption.
Cheryl Guttman Krader
Published: Monday, March 13, 2017
Retina specialists who perform subthreshold micropulse laser treatment may feel as if they are performing ‘retinal homeopathy'IMPEDIMENTS TO GREATER USE Dr. Gerardo suggested that despite the evidence demonstrating its efficacy and safety, subthreshold micropulse laser has faced several obstacles to adoption. First, laser in general is considered less effective than anti-VEGF therapy, and subthreshold micropulse laser treatment is a latecomer to the treatment armamentarium compared with anti-VEGF injections. In addition, the fact that the subthreshold micropulse modality does not produce visible lesions may create skepticism about whether the treatment is really doing anything. “Retina specialists who perform subthreshold micropulse laser treatment may feel as if they are performing ‘retinal homeopathy’,” Dr. Garcia said. Although we do not have a lot of tools to prove it, findings from imaging with scanning laser opthalmoscopy and spectral domain optical coherence tomography provide evidence that subthreshold micropulse laser does cause a biologic effect. (AM J Opthalmolol 2010:150:856-862) The absence of visible lesions with subthreshold micropulse laser treatment also made it difficult to track treated areas using lasers delivering single spots. This issue, however, has been addressed by the introduction of pattern laser delivery systems that provide better spot coverage without overlap while also increasing treatment efficiency.
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.